Citius Oncology Growth Metrics (2022-2026) | CTOR

1Y3Y5Y7Y10YAll
Download Data
Growth Metrics Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Growth Ratios
Assets Growth (1y) (Quarter) 53,838.68%18,492.34%6.50%-29.26%-29.57%76.74%24.59%87.84%86.42%19.64%21.54%10.13%
Assets Growth (3y) (Quarter) 794.50%632.58%17.27%13.53%
Assets (QoQ) (Quarter) 26,459.57%0.92%1.50%-31.66%52.14%-32.97%1.06%71.50%7.25%1.06%0.29%10.07%8.95%-8.43%
Cash & Equivalents Growth (1y) (Quarter) -72.31%-99.58%-99.66%3,504,282.14%6,513,695.54%2,350,466.07%
Cash & Equivalents Growth (3y) (Quarter) 193.29%179.65%
Cash & Equivalents (QoQ) (Quarter) -58.37%207.45%-92.83%0.00%0.00%0.00%3,504,282.14%85.88%-63.91%
Cash from Investing Activities (QoQ) (Quarter) -99.72%86.36%
Cash from Operations Growth (1y) (Quarter) -13.56%-265.17%
Cash from Operations Growth (3y) (Quarter) -183.14%
Cash from Operations (QoQ) (Quarter) 40.61%-281.55%-90.99%47.90%
EBITDA Margin (QoQ) (Quarter) -158300.00
EBIT Growth (1y) (Quarter) -81.47%-2,219.60%-39.52%-2,683.35%-6.83%17.87%-282.98%
EBIT Growth (3y) (Quarter) -478.34%
EBIT Margin (QoQ) (Quarter) -158300.00
EBIT (QoQ) (Quarter) -34.90%-111.20%-987.52%94.14%-1,624.42%-16.83%33.81%4.72%-11.48%-444.78%
EBT Growth (1y) (Quarter) -3,071.64%-2,219.60%-39.52%-59.25%-10.30%17.59%-259.25%
EBT Growth (3y) (Quarter) -466.14%
EBT Margin (QoQ) (Quarter) -147623.00
EBT (QoQ) (Quarter) -34.90%-111.20%-987.52%-2.36%1.34%-16.83%31.66%7.31%-11.36%-409.33%
Enterprise Value Growth (1y) (Quarter) 72.31%99.58%99.66%-3,504,282.14%-6,513,695.54%-2,350,466.07%
Enterprise Value Growth (3y) (Quarter) -193.29%-179.65%
Enterprise Value (QoQ) (Quarter) 58.37%-207.45%92.83%0.00%0.00%0.00%-3,504,282.14%-85.88%63.91%
EPS (Basic) Growth (1y) (Quarter) -200.00%-200.00%-28.57%-57.14%-14.29%33.33%-145.45%
EPS (Basic) Growth (3y) (Quarter) -80.26%
EPS (Basic) (QoQ) (Quarter) 0.00%-71.43%-450.00%0.00%0.00%-22.22%27.27%25.00%0.00%-350.00%
EPS (Weighted Average and Diluted) Growth (1y) (Quarter) -200.00%-200.00%-28.57%-57.14%-14.29%33.33%-145.45%
EPS (Weighted Average and Diluted) Growth (3y) (Quarter) -80.26%
EPS (Weighted Average and Diluted) (QoQ) (Quarter) 0.00%-71.43%-450.00%0.00%0.00%-22.22%27.27%25.00%0.00%-350.00%
FCF Margin (QoQ) (Quarter) -4333.00
Free Cash Flow Growth (1y) (Quarter) -13.56%-265.17%
Free Cash Flow Growth (3y) (Quarter) -183.14%
Free Cash Flow (QoQ) (Quarter) 40.61%-281.55%-90.99%47.90%
Gross Margin (QoQ) (Quarter) 28.00
Gross Profit (QoQ) (Quarter) -57.58%
Interest Coverage Ratio (QoQ) (Quarter) -167.41%99.65%-491.94%
Net Cash Flow Growth (1y) (Quarter) 100.35%67.02%
Net Cash Flow Growth (3y) (Quarter) -202.29%
Net Cash Flow (QoQ) (Quarter) 40.61%-161.98%-5,762.50%-238.34%
Net Income Growth (1y) (Quarter) -3,168.98%-2,291.76%-40.86%-59.97%-12.51%16.90%-243.99%
Net Income Growth (3y) (Quarter) -464.51%
Net Income (QoQ) (Quarter) -34.90%-111.20%-1,021.69%-2.29%1.30%-16.16%30.58%6.95%-10.76%-380.83%
Net Income towards Common Stockholders Growth (1y) (Quarter) -3,168.98%-2,291.76%-40.86%-59.97%-12.51%16.90%-243.99%
Net Income towards Common Stockholders Growth (3y) (Quarter) -464.51%
Net Income towards Common Stockholders (QoQ) (Quarter) -34.90%-111.20%-1,021.69%-2.29%1.30%-16.16%30.58%6.95%-10.76%-380.83%
Net Margin (QoQ) (Quarter) -145566.00
Operating Income Growth (1y) (Quarter) -81.47%-2,219.60%-2,683.35%-6.83%17.87%-282.98%
Operating Income Growth (3y) (Quarter) -478.34%
Operating Income (QoQ) (Quarter) -34.90%-111.20%-1,624.42%-16.83%33.81%4.72%-11.48%-444.78%
Operating Margin (QoQ) (Quarter) -158300.00
Profit After Tax Growth (1y) (Quarter) -890.48%-874.44%-40.86%-59.97%-12.51%16.90%-243.99%
Profit After Tax Growth (3y) (Quarter) -257.00%
Profit After Tax (QoQ) (Quarter) 0.75%-74.37%-3,093.11%-2.29%1.30%-16.16%30.58%6.95%-10.76%-380.83%
Return on Assets Growth (1y) (Quarter) 0.000.000.000.000.000.000.000.000.00
Return on Assets Growth (3y) (Quarter) 0.00
Return on Assets (QoQ) (Quarter) 0.000.000.000.000.000.000.000.000.000.000.000.00
Return on Capital Employed Growth (1y) (Quarter) -2685.00-3606.00-3916.00-78.00-4803.00
Return on Capital Employed (QoQ) (Quarter) -26.00-1213.00-946.00-1523.001,053.001,338.00-5671.00
Return on Equity Growth (1y) (Quarter) 0.003.000.000.000.000.000.000.000.00
Return on Equity Growth (3y) (Quarter) 0.00
Return on Equity (QoQ) (Quarter) -3.003.000.000.000.000.000.000.000.000.000.000.00
Return on Invested Capital Growth (1y) (Quarter) 0.000.00
Return on Invested Capital (QoQ) (Quarter) 0.000.000.000.000.00
Return on Sales (QoQ) (Quarter) -15.00
Revenue (QoQ) (Quarter) -57.73%
Share-based Compensation Growth (1y) (Quarter) -5.66%-46.09%8.60%118.75%68.86%
Share-based Compensation (QoQ) (Quarter) 102.09%-49.48%15.49%1.76%-1.45%88.89%-10.85%
Shareholder's Equity Growth (1y) (Quarter) 3,516.47%-29.59%6,477.35%9,944.59%865,489.28%80.69%81.69%79.59%90.23%-2.76%41.47%-1.05%
Shareholder's Equity Growth (3y) (Quarter) 1,498.54%7.35%452.95%463.05%
Shareholder's Equity (QoQ) (Quarter) -99.05%-42.81%-101.00%1,297,643.70%-11.01%-12.67%-14.19%170.92%-10.51%-13.68%-9.10%38.48%30.20%-39.62%
Tax Rate Growth (1y) (Quarter) -99.00-47.00-206.00-88.00440.00
Tax Rate (QoQ) (Quarter) 7.00-4.0060.00-164.00-41.0057.00588.00